CFDE Data Portal | Search MMP11

	Label	Description
	MMP11 Gene (Entity type)	ENSG00000099953 - matrix metallopeptidase 11
	MMP11 associations Collection (Entity type)	Associations for MMP11_associations
	MMP11 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MMP11 Gene (Entity type)	matrix metallopeptidase 11 [Source:HGNC Symbol;Acc:HGNC:7157]
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE145990 1 V 0 IBRUTINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 etoposide leukocyte 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE220806 progesterone fibroblast 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 4 V 1 ETOPOSIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

MMP11

ENSG00000099953 - matrix metallopeptidase 11

MMP11 associations

Associations for MMP11_associations

MMP11 associations.tsv

A file from IDG as part of the Harmonizome project

MMP11

matrix metallopeptidase 11 [Source:HGNC Symbol;Acc:HGNC:7157]

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE145990 1 V 0 IBRUTINIB HUMAN UP

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE120612 etoposide leukocyte 6 v 1 human up

A Gene Set from LINCS

GSE220806 progesterone fibroblast 1 v 3 human dn

A Gene Set from LINCS

GSE120612 4 V 1 ETOPOSIDE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.